• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

指南依从性作为抗栓药物过度和不足使用程度的指标:一项系统评价。

Guideline Adherence As An Indicator of the Extent of Antithrombotic Overuse and Underuse: A Systematic Review.

机构信息

Institute for Evidence Based Healthcare, Bond University, Gold Coast, QLD, Australia.

Evidence Based Practice Professorial Unit, Gold Coast University Hospital, Southport, QLD, Australia.

出版信息

Glob Heart. 2022 Aug 12;17(1):55. doi: 10.5334/gh.1142. eCollection 2022.

DOI:10.5334/gh.1142
PMID:36051325
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9374022/
Abstract

Thromboembolic events are a common risk in adults with atrial fibrillation, those with previous cerebrovascular accidents and undergoing emergency or elective surgeries. The widespread availability of antithrombotic agents and differing guidelines contribute to practice variations and increased risk of complications and deaths. The objective of this review was to investigate the extent of overuse and underuse of antithrombotics for primary or secondary prevention as measured by deviation from prescribing guideline recommendations. We conducted a systematic review of Medline and EMBASE for quantitative articles published between 2000 and 2021 and used a modified version of the Hoy's risk of bias assessment tool. Here we report evidence from the past decade about wide practice variations in hospitals and primary care, and discuss clinician and patient-driven determinants of non-adherence to guidelines. Finally, we summarise implications for practice, identify enhanced ways of measuring overuse and underuse, and propose potential solutions to the measurement challenges.

摘要

血栓栓塞事件是心房颤动、既往有脑血管意外和接受紧急或择期手术的成年人的常见风险。抗血栓药物的广泛应用和不同的指南导致了实践中的差异,并增加了并发症和死亡的风险。本综述的目的是调查抗血栓药物的过度使用和使用不足的程度,这是通过偏离处方指南建议来衡量的。我们对 2000 年至 2021 年期间发表的定量文章进行了 Medline 和 EMBASE 的系统回顾,并使用了 Hoy 偏倚风险评估工具的修改版本。在这里,我们报告了过去十年中关于医院和初级保健中广泛的实践差异的证据,并讨论了临床医生和患者驱动的不遵守指南的决定因素。最后,我们总结了对实践的影响,确定了衡量过度使用和使用不足的改进方法,并提出了衡量挑战的潜在解决方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793f/9374022/ef76ee4afd8f/gh-17-1-1142-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793f/9374022/24ff10a284d7/gh-17-1-1142-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793f/9374022/b380823f974d/gh-17-1-1142-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793f/9374022/8bcef72dff37/gh-17-1-1142-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793f/9374022/ef76ee4afd8f/gh-17-1-1142-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793f/9374022/24ff10a284d7/gh-17-1-1142-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793f/9374022/b380823f974d/gh-17-1-1142-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793f/9374022/8bcef72dff37/gh-17-1-1142-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793f/9374022/ef76ee4afd8f/gh-17-1-1142-g4.jpg

相似文献

1
Guideline Adherence As An Indicator of the Extent of Antithrombotic Overuse and Underuse: A Systematic Review.指南依从性作为抗栓药物过度和不足使用程度的指标:一项系统评价。
Glob Heart. 2022 Aug 12;17(1):55. doi: 10.5334/gh.1142. eCollection 2022.
2
Interventions for promoting habitual exercise in people living with and beyond cancer.促进癌症患者及康复者进行习惯性锻炼的干预措施。
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
3
Thrombolysis for acute ischaemic stroke.急性缺血性脑卒中的溶栓治疗
Cochrane Database Syst Rev. 2003(3):CD000213. doi: 10.1002/14651858.CD000213.
4
Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without dementia.抗血栓治疗预防神经影像学检查发现的小血管疾病但无痴呆的患者认知能力下降。
Cochrane Database Syst Rev. 2022 Jul 14;7(7):CD012269. doi: 10.1002/14651858.CD012269.pub2.
5
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
6
Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.双嘧达莫用于预防血管疾病患者的中风及其他血管事件。
Cochrane Database Syst Rev. 2003(1):CD001820. doi: 10.1002/14651858.CD001820.
7
Review of guidelines for good practice in decision-analytic modelling in health technology assessment.卫生技术评估中决策分析模型良好实践指南综述。
Health Technol Assess. 2004 Sep;8(36):iii-iv, ix-xi, 1-158. doi: 10.3310/hta8360.
8
Non-clinical interventions for reducing unnecessary caesarean section.减少不必要剖宫产的非临床干预措施。
Cochrane Database Syst Rev. 2018 Sep 28;9(9):CD005528. doi: 10.1002/14651858.CD005528.pub3.
9
Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery.用于预防股腘动脉旁路移植术后血栓形成的抗血栓药物。
Cochrane Database Syst Rev. 2003(4):CD000536. doi: 10.1002/14651858.CD000536.
10
Interventions for palliative symptom control in COVID-19 patients.干预措施以控制 COVID-19 患者的姑息症状。
Cochrane Database Syst Rev. 2021 Aug 23;8(8):CD015061. doi: 10.1002/14651858.CD015061.

引用本文的文献

1
Barriers to Optimal Clinician Guideline Adherence in the Management of Markedly Elevated Blood Pressure: A Qualitative Content Analysis of Electronic Health Records.显著高血压管理中临床医生最佳遵循指南的障碍:电子健康记录的定性内容分析
medRxiv. 2024 Jan 13:2024.01.12.24301223. doi: 10.1101/2024.01.12.24301223.

本文引用的文献

1
Effect of an artificial intelligence-assisted tool on non-valvular atrial fibrillation anticoagulation management in primary care: protocol for a cluster randomized controlled trial.人工智能辅助工具对初级保健中非瓣膜性心房颤动抗凝管理的影响:一项集群随机对照试验方案。
Trials. 2022 Apr 15;23(1):316. doi: 10.1186/s13063-022-06250-8.
2
Prescribing of direct oral anticoagulants and warfarin to older people with atrial fibrillation in UK general practice: a cohort study.在英国的普通实践中,为患有心房颤动的老年人开直接口服抗凝剂和华法林处方:一项队列研究。
BMC Med. 2021 Aug 31;19(1):189. doi: 10.1186/s12916-021-02067-5.
3
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
4
Antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention, including compliance with current guidelines-data from the POLish Atrial Fibrillation (POL-AF) Registry.接受经皮冠状动脉介入治疗的心房颤动患者的抗栓治疗,包括遵循现行指南——来自波兰心房颤动(POL-AF)注册研究的数据
Cardiovasc Diagn Ther. 2021 Feb;11(1):14-27. doi: 10.21037/cdt-20-839.
5
Non-vitamin K antagonist oral anticoagulant (NOAC) use and dosing in Canadian practice: Insights from the optimising pharmacotherapy in the management approach to lowering risk in atrial fibrillation (OPTIMAL AF) Programme.加拿大临床中新型口服抗凝药(NOAC)的应用和剂量选择:优化心房颤动管理策略以降低风险的药物治疗(OPTIMAL AF)项目获得的相关认识。
Int J Clin Pract. 2020 Dec;74(12):e13625. doi: 10.1111/ijcp.13625. Epub 2020 Aug 27.
6
Accuracy of machine learning-based prediction of medication adherence in clinical research.基于机器学习的临床研究中药物依从性预测的准确性。
Psychiatry Res. 2020 Dec;294:113558. doi: 10.1016/j.psychres.2020.113558. Epub 2020 Nov 4.
7
Outpatient management of patients presenting with venous thromboembolism: Retrospective cohort study at 11 community hospitals.门诊管理静脉血栓栓塞症患者:11 家社区医院的回顾性队列研究。
J Thromb Thrombolysis. 2021 Jul;52(1):179-188. doi: 10.1007/s11239-020-02328-9. Epub 2020 Nov 7.
8
Computerised clinical decision support systems and absolute improvements in care: meta-analysis of controlled clinical trials.计算机化临床决策支持系统与护理质量的绝对改善:对照临床试验的荟萃分析。
BMJ. 2020 Sep 17;370:m3216. doi: 10.1136/bmj.m3216.
9
Analysis of Atrial Fibrillation Treatment Regimes in a Multicenter Cohort of Transcatheter Edge-to-Edge Mitral Valve Repair Patients.经导管缘对缘二尖瓣修复术患者多中心队列中心房颤动治疗方案分析。
J Interv Cardiol. 2020 Aug 28;2020:6542028. doi: 10.1155/2020/6542028. eCollection 2020.
10
Stroke prevention and guideline adherent antithrombotic treatment in elderly patients with atrial fibrillation: A real-world experience.老年心房颤动患者的卒中预防及遵循指南的抗栓治疗:一项真实世界经验
Medicine (Baltimore). 2020 Jul 17;99(29):e21209. doi: 10.1097/MD.0000000000021209.